Nuvation Drug Patent Portfolio
Nuvation owns 1 orange book drug protected by 2 US patents Given below is the list of Nuvation's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9187489 | Imidazo[1,2-b]pyridazine derivatives as kinase inhibitors | 03 Jun, 2033 | Active |
| US9751887 | Imidazo[1,2-b]pyridazine derivatives as kinase inhibitors | 03 Jun, 2033 | Active |
Nuvation's Family Patents
Nuvation Drug List
Given below is the complete list of Nuvation's drugs and the patents protecting them.
1. Ibtrozi
Ibtrozi is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9187489 | Imidazo[1,2-b]pyridazine derivatives as kinase inhibitors |
03 Jun, 2033
(7 years from now)
| Active |
| US9751887 | Imidazo[1,2-b]pyridazine derivatives as kinase inhibitors |
03 Jun, 2033
(7 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ibtrozi's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List